InsidersTradesSigma
리브스메드 Stock: price and directors' dealings · South Korea · DART (FSS)
Follow the 리브스메드 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares trade on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 리브스메드 has recorded 21 reports. Market capitalisation: €1,019.4bn. The latest transaction was reported on 22 April 2026 (Purchase). Among the most active insiders: 스톤브릿지벤처스. The full history is openly available.
21
Insider Decl.
0
Thresholds
·
5 ops.
Buy Volume
·
6 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate 리브스메드 Strong Buy (bullish), based on 1 analysts. Average price target: ₩120,000.
16Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 22 April 2026
Declarations21 total
1,465,662 sharesKRXDART:20260407003261
Ideal exit: 20 Sept 2026 (T+270)
21 of 21 declarations